ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
PUL is superior to BPH medical therapy in preserving sexual function
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 194044" data-attributes="member: 13851"><p><em><strong>*Within the treatment space for LUTS/BPH, a blockers and 5a-reductase inhibitors (5-ARIs), either alone or in combination, have gained a stronghold as first-line therapy. Although they have demonstrated clinical efficacy, their use has been associated with sexual side effects, which vary in rate among different drug classes and between members in the same class [9,10]. For example, 5-ARIs have been associated with sexual adverse events such as ED, EjD, change in libido, and gynecomastia. Alpha-blockers have been linked to impaired ejaculation where the super-selective tamsulosin and silodosin have been associated with EjD, including lower ejaculate volume and anejaculation [9].</strong></em></p><p><em></em></p><p><em></em></p><p><strong><em>*Conversely, the prostatic urethral lift (PUL) procedure using UroLift System implants is the only leading minimally invasive surgical therapy that offers rapid, significant, and durable symptom relief of LUTS without causing new sustained ED or EjD [11–15]. </em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 194044, member: 13851"] [I][B]*Within the treatment space for LUTS/BPH, a blockers and 5a-reductase inhibitors (5-ARIs), either alone or in combination, have gained a stronghold as first-line therapy. Although they have demonstrated clinical efficacy, their use has been associated with sexual side effects, which vary in rate among different drug classes and between members in the same class [9,10]. For example, 5-ARIs have been associated with sexual adverse events such as ED, EjD, change in libido, and gynecomastia. Alpha-blockers have been linked to impaired ejaculation where the super-selective tamsulosin and silodosin have been associated with EjD, including lower ejaculate volume and anejaculation [9].[/B] [/I] [B][I]*Conversely, the prostatic urethral lift (PUL) procedure using UroLift System implants is the only leading minimally invasive surgical therapy that offers rapid, significant, and durable symptom relief of LUTS without causing new sustained ED or EjD [11–15]. [/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
PUL is superior to BPH medical therapy in preserving sexual function
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top